A novel blood test for identifying damage to the lining of microscopic blood vessels could transform the ability to detect heart and kidney disease at its very earliest stages, suggests new research.
Until now, monitoring the health of the vast network of tiny blood vessels that supply vital organs with oxygen and nutrients has remained largely inaccessible to medicine. In this new study, published in Nature Communications, scientists show that damage to the lining of these microscopic blood vessels signals the earliest stages of heart and kidney disease, conditions that together account for one in three deaths worldwide.
Previously, detecting this type of vascular damage relied on invasive tissue biopsies and advanced microscopy techniques. In this breakthrough, a research team based at the University of Bristol demonstrate a new way to identify damage to the blood vessel lining by tracking changes in the sugar‑ and protein‑rich coating on the surface of these vessels, known as the glycocalyx.
This thin, protective layer lines the inside of our blood vessels, but it is highly sensitive and can change rapidly at the earliest signs of illness. The glycocalyx also acts as a crucial barrier, regulating what moves in and out of the bloodstream and directing immune cells to where they are needed. When the glycocalyx becomes damaged, researchers show that it serves as the earliest marker of disease.
Using advanced chemical techniques, the team demonstrated that as blood circulates around the body, red blood cells and blood vessel walls continuously exchange components of this protective coating when they come into contact. Importantly, they found that the transfer of the glycocalyx onto red blood cells creates a biochemical ‘imprint’ that closely reflects the condition of the blood vessel lining.
This discovery paves the way for a simple blood test that could allow doctors to detect blood vessel damage and assess a person’s risk of developing heart‑ and kidney‑related diseases at an earlier stage than ever before. Together, these findings offer a completely new way to detect and monitor vascular disease through routine blood testing.
Dr Matthew Butler, the study’s first author, Consultant Senior Lecturer and MRC Clinician Scientist at the University of Bristol and Honorary Nephrology Consultant at North Bristol NHS Trust (NBT), explains: “The health of our blood vessels is central to our overall health and monitoring blood vessel damage has been a routine part of healthcare for decades. However, a huge portion of the vascular system is currently inaccessible to doctors and scientists because the vessels are too small to be seen. Our results suggest that we can use changes occurring at the surface of red blood cells to identify microscopic blood vessel damage before other markers become detectable. Most excitingly, we can also rapidly detect when drugs are effective at restoring the blood vessel lining. These findings could transform our ability to spot and treat disease before it progresses to become potentially irreversible or life threatening.”
Simon Satchell, Professor of Renal and Vascular Medicine at the University of Bristol and the study’s last author, added: “Our findings provide a powerful tool for identifying potential health issues at a much earlier stage. This discovery could pave the way for proactive, preventative healthcare, offering the possibility of addressing diseases before they develop.”
The study was directly funded by the Medical Research Council (MRC) and Kidney Research UK (KRUK). The British Heart Foundation (BHF) and Diabetes UK funded one or more of the co-authors.
- Butler MJ, Ramnath RR, Crompton M, et al. Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function. Nat Commun. 2026;17(1):3568. doi:10.1038/s41467-026-71848-4